Long-Term Effects of Angiotensin II Receptor Blockade with Valsartan on Carotid Arterial Stiffness and Hemodynamic Alterations in Patients with Essential Hypertension

Author： Okura Takafumi   Watanabe Sanae   Kurata Mie   Koresawa Mitsuko   Irita Jun   Enomoto Daijiro   Jotoku Masanori   Miyoshi Ken-Ichi   Fukuoka Tomikazu   Higaki Jitsuo  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.30, Iss.5, 2008-07, pp. : 415-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Effects of the Angiotensin Receptor Blocker Candesartan on Arterial Stiffness and Markers of Extracellular Matrix Metabolism in Patients with Essential Hypertension

By Sasamura Hiroyuki   Kitamura Yudai   Nakamura Mari   Ryuzaki Munekazu   Saruta Takao  

Clinical and Experimental Hypertension, Vol. 28, Iss. 5, 2006-06 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Life after LIFE. Cardiovascular benefits of angiotensin II receptor blockade in older people with essential hypertension, left ventricular hypertrophy and diabetes mellitus

By Giacomelli V.O.   Singer D.R.J.  

European Journal of Internal Medicine, Vol. 13, Iss. 6, 2002-09 ,pp. : 353-355

Elsevier

Access to resources Recommend Favorite

The Effects of Angiotensin II Signaling Blockade on Platelet Activity in Subjects with Hypertension

By  

Current Hypertension Reviews, Vol. 11, Iss. 2, 2015-07 ,pp. : 116-122

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite